Related Experiment Video
Updated: May 2, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
Correlation between carbapenem susceptibility in Pseudomonas aeruginosa and modified antibiotic heterogeneity index:
Keisuke Sawada1,2,3, Takaaki Kato2, Shuji Kono1
1Department of Pharmacy, Federation of National Public Service Personnel Mutual Aid Associations Hirakata Kohsai Hospital, Osaka, Japan.
Objective:
This study focused on exploring the relationship between antimicrobial use indicators, including the modified antibiotic heterogeneity index (mAHI), and the carbapenem susceptibility in Pseudomonas aeruginosa.
Design:
Survey-based observational study conducted across multiple facilities.
Setting:
Public community hospital institutions.
Methods:
This survey was conducted in 15 community hospitals in Japan. Indicators, such as the defined daily doses (DDDs), days of therapy (DOTs), antibiotic heterogeneity index (AHI), and mAHI, were analyzed for P. aeruginosa carbapenem susceptibility using Spearman's rank correlation. The predictive accuracies of the AHI and mAHI for carbapenem susceptibility were compared using DeLong's test for the 2 correlated receiver operating characteristic curves.
Results:
No significant correlations were observed between DDDs or DOTs and carbapenem susceptibility. However, a significant correlation was observed between carbapenem susceptibility and the mAHI (r = 0.261, P = .02), which also demonstrated a higher predictive accuracy for high susceptibility rates than that of the AHI (area under the curve: 0.75 vs 0.58, p < .01). The optimal mAHI cutoff value for predicting 90% susceptibility was 0.765, with a sensitivity of 67.7% and specificity of 76.5%.
Conclusions:
The mAHI may be a better predictor of carbapenem susceptibility than other commonly used indicators. This study underscores the utility of the mAHI as an effective indicator of antimicrobial usage patterns for managing carbapenem susceptibility in P. aeruginosa. Incorporating the mAHI into antimicrobial stewardship programs could enhance the effectiveness of antimicrobial interventions across diverse healthcare settings.
Insights
The modified antibiotic heterogeneity index (mAHI) better predicts carbapenem susceptibility in Pseudomonas aeruginosa than other common indicators. This finding supports using mAHI in antimicrobial stewardship to manage resistance.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Antimicrobial Stewardship
Background:
- Carbapenem resistance in Pseudomonas aeruginosa is a significant global health threat.
- Effective antimicrobial stewardship requires accurate indicators of antimicrobial use.
- Existing indicators like Defined Daily Doses (DDDs) and Days of Therapy (DOTs) may not fully capture resistance patterns.
Purpose of the Study:
- To investigate the relationship between antimicrobial use indicators and carbapenem susceptibility in Pseudomonas aeruginosa.
- To evaluate the modified antibiotic heterogeneity index (mAHI) as a predictor of carbapenem susceptibility.
- To compare the predictive accuracy of mAHI against other common antimicrobial use indicators.
Main Methods:
- A survey-based observational study was conducted in 15 community hospitals in Japan.
- Antimicrobial use indicators including DDDs, DOTs, Antibiotic Heterogeneity Index (AHI), and mAHI were analyzed.
- Spearman's rank correlation and DeLong's test for receiver operating characteristic curves were used to assess correlations and predictive accuracies.
Main Results:
- No significant correlation was found between DDDs or DOTs and carbapenem susceptibility.
- A significant positive correlation was observed between carbapenem susceptibility and mAHI (r = 0.261, P = .02).
- mAHI demonstrated higher predictive accuracy (AUC = 0.75) for carbapenem susceptibility compared to AHI (AUC = 0.58), with an optimal cutoff of 0.765 for predicting 90% susceptibility.
Conclusions:
- The mAHI is a more effective predictor of carbapenem susceptibility in Pseudomonas aeruginosa than traditional indicators.
- mAHI can inform antimicrobial usage patterns and aid in managing carbapenem resistance.
- Integrating mAHI into antimicrobial stewardship programs can enhance intervention effectiveness in healthcare settings.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance